Clinical Trials
4
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
BVA-200 vs BVA-100 Validation Study
- Conditions
- Kidney DiseasesTraumaOther DiseaseClotting DisorderHigh CholesterolThyroid DiseasesHeart FailureAnemiaDiabetesHigh Blood Pressure
- First Posted Date
- 2024-01-29
- Last Posted Date
- 2024-01-29
- Lead Sponsor
- Daxor Corporation
- Target Recruit Count
- 62
- Registration Number
- NCT06227819
- Locations
- 🇺🇸
Daxor Corporation, Oak Ridge, Tennessee, United States
Evaluation of Blood Volume Analysis- Guided Management of Decompensated Heart Failure
- Conditions
- Acute Decompensated Heart Failure
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Daxor Corporation
- Target Recruit Count
- 32
- Registration Number
- NCT04855097
- Locations
- 🇺🇸
VA Boston Healthcare System, Boston, Massachusetts, United States
Monitoring Outpatient Blood VolumE in Heart Failure
- Conditions
- Heart Failure
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2023-09-29
- Lead Sponsor
- Daxor Corporation
- Target Recruit Count
- 15
- Registration Number
- NCT04660396
- Locations
- 🇺🇸
Geisinger, Danville, Pennsylvania, United States
Total Body Albumin Measurement Utilizing a Modification of the BVA 100 Blood Volume Analyzer
- Conditions
- HypoalbuminemiaHeart FailureNephrosisCirrhosisShock
- First Posted Date
- 2012-03-02
- Last Posted Date
- 2012-03-02
- Lead Sponsor
- Daxor Corporation
- Target Recruit Count
- 20
- Registration Number
- NCT01542749
News
Daxor Submits FDA 510(k) for Next-Generation Blood Volume Analyzer with Enhanced Point-of-Care Capabilities
Daxor Corporation has submitted its next-generation blood volume analyzer (Daxor BVA) to the FDA for 510(k) clearance, designed to process tests three times faster than its predecessor.
Blood Volume Analysis Outperforms Traditional Methods in Heart Failure Assessment, Multicenter Study Shows
A new multicenter study across three major medical institutions demonstrates Daxor's Blood Volume Analysis (BVA) provides superior accuracy over conventional pressure-based measurements in heart failure patients.